1. Home
  2. LUV vs RPRX Comparison

LUV vs RPRX Comparison

Compare LUV & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southwest Airlines Company

LUV

Southwest Airlines Company

HOLD

Current Price

$41.02

Market Cap

19.4B

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$54.40

Market Cap

22.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUV
RPRX
Founded
1967
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4B
22.0B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
LUV
RPRX
Price
$41.02
$54.40
Analyst Decision
Hold
Strong Buy
Analyst Count
18
5
Target Price
$45.37
$51.40
AVG Volume (30 Days)
6.4M
2.9M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
1.93%
1.90%
EPS Growth
3.95
N/A
EPS
0.45
0.67
Revenue
N/A
$2,378,193,000.00
Revenue This Year
$16.57
$38.63
Revenue Next Year
$3.61
$4.73
P/E Ratio
$90.16
$79.72
Revenue Growth
N/A
5.06
52 Week Low
$28.98
$32.21
52 Week High
$55.11
$53.53

Technical Indicators

Market Signals
Indicator
LUV
RPRX
Relative Strength Index (RSI) 55.57 73.44
Support Level $36.29 $35.35
Resistance Level $42.76 N/A
Average True Range (ATR) 1.37 1.08
MACD 0.18 0.15
Stochastic Oscillator 72.09 98.66

Price Performance

Historical Comparison
LUV
RPRX

About LUV Southwest Airlines Company

Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated with a simple cabin configuration in a point-to-point network. In early 2026, Southwest modified its cabins to offer some rows with extra legroom, its ticketing process and merchandising to offer assigned seats, and more fare categories to include a basic economy class that appears for the first time in travel aggregators' search results and more directly competes with other airlines' offerings.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: